An internationally recognized clinician-scientist known for his work in the areas of arthritis, rheumatology and immunology, Dr. Bridges’ work has advanced health disparities in rheumatology patient care.
Dr. Crow provided an analysis on new findings involving the overproduction of type 1 interferon in lupus. The research has yielded data on one of the mechanisms that might explain why interferon is being made in excess in lupus.
The editorial notes that there is a challenge in designing clinical trials for lupus in terms of selection of outcomes instruments and suggests a remedy.
Dr. Christian, who achieved major advances in the pathogenesis of rheumatoid arthritis and in systemic lupus erythematosus (SLE), was beloved by colleagues, trainees, and friends throughout the United States and around the world.
Dr. Salmon has been at the forefront of research in rheumatic disease, particularly systemic lupus erythematosus, for several decades.
Dr. Salmon will oversee Weill Cornell Medicine's Office of Faculty Affairs, working closely with Assistant Dean of Faculty Affairs Mark Albano, senior leadership, and department chairs to implement best practices for appointments, promotions, and tenure actions. She will also coordinate with the Office of Faculty Development and the Office of Diversity and Inclusion on behalf of clinical, teaching and research faculty.
In this multicenter study, Dr. Salmon and colleagues identified clinical and laboratory predictors of adverse pregnancy outcomes in women who have inactive or stable-mild active lupus.
Membership to the AAP is a coveted honor and reflects remarkable dedication to the advancement of scientific and practical medicine. Founded in 1885 as a non-profit professional organization, the AAP has some 1,300 active members and 600 honorary members.
Drs. Vivian Bykerk, Lionel B. Ivashkiv, and Alessandra B. Pernis of the Division of Rheumatology will serve as key researchers in one of the 11 research groups across the United States that comprise the NIH Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Network. Rheumatoid Arthritis and Lupus, which can be devastating, are relatively common and severe autoimmune diseases.
Dr. Vivian Bykerk, on staff at the Hospital for Special Surgery (HSS) and an Associate Professor of Medicine (Department of Medicine) at Weill Cornell, presented advances in arthritis research at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professions. The message of the new findings was: Delaying treatment for rheumatoid arthritis can greatly increase the likelihood of worse function at two years.